US5935996A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Composition for stimulating osteogenesis and preventingreduction of bone salt
Assignee: Taishi Foods Co Ltd
•
Filing: 1997-09-30
•
Granted: 1999-08-10
•
Expires: 2017-09-30
Abstract
Abstract It is an object of this invention to provide a composition capable of being used for foods and pharmaceuticals, which stimulates osteogenesis and has an effect for preventing reduction of a bone salt content, and which is useful for therapy and prevention of osteoporosis, fracture and the like. The composition is characterized by containing an isoflavone as a main active ingredient. The composition be preferably ingested so that the concentration of genistein in blood in one hour after ingestion is 10 -7 M or more. Further preferably, the composition contains zinc salt whose concentration in blood is 10 -7 M or more.
Inventors
- 👤 Masayoshi Yamaguchi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 05:24
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/24; A61K33/30; A61P; A61P19/00; A61P19/08; A61P19/10; A61P3/00; A61P3/12; A61P3/14; A61P43/00
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
47 words
A method for accelerating ossification and preventing reduction of bone salt content which comprises administering to a mammal in need thereof an effective amount for accelerating ossification and preventing reduction of bone salt content of a composition containing synergistic effective amounts of genistein and a zinc salt.
Claim 2
Independent Claim
47 words
A method for accelerating ossification and preventing reduction of bone salt content which comprises administering to a mammal in need thereof an effective amount for accelerating ossification and preventing reduction of bone salt content of a composition containing synergistic effective amounts of genistein and a zinc salt.
Claim 3
Dependent Claim
13 words
A pharmaceutical composition comprising synergistic effective amounts of genistein and a zinc salt.
Claim 4
Dependent Claim
13 words
A pharmaceutical composition comprising synergistic effective amounts of genistein and a zinc salt.
Claim 5
Dependent Claim
8 words
The composition of claim 2, further comprising tofu.
References Cited (Backward Citations)
US5506211A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-08-09 | 2003-02-08 | 2003-08-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-08-09 | 2007-02-08 | 2007-08-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-08-09 | 2011-02-08 | 2011-08-10 | $7700.00 | Window Closed / Lapsed |